Back to Agenda
TFDA Town Hall: Focus on Regenerative Medicine
Session Chair(s)
Shou-Mei Wu, PhD
Director-General, TFDA, Taiwan
Regenerative medicine is a potential treatment that can help repair or replace damaged or diseased human cells or tissues to restore normal function. This forum will discuss the regulatory aspects and experience with regenerative medicine.
Learning Objective : Discuss regulations governing implementation or use of specific medical technology, examination, laboratory testing and medical devices; Describe the management of regenerative pharmaceutical products; Describe the experience of reviewing regenerative medicine affairs.
Speaker(s)
Chung-Liang Shih, PhD
Director-General, Department of Medical Affairs, Ministry of Health & Welfare, Taiwan
New Regulation on Cell Therapy: Challenge and Prospect
Lien-Cheng Chang, PhD
Senior Secretary, Department of Intellectual Property and Technology Transfer, Academia Sinica, Taiwan
Regulation of Cell and Gene Therapy Products
I-Ning Tang, MD, MSc
Section Chief, Regulatory Science, Center for Drug Evaluation (CDE), Taiwan
Regulatory Considerations and Experiences for the Evaluation of Regenerative Medicinal Products
Have an account?